Skip NavigationMarketsBusinessInvestingTechPoliticsVideoWatchlistInvesting Club
PRO
LivestreamMenuEvery weekday, the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. 1. The major Wall Street averages rose Tuesday, supported by chipmakers like Micron , Marvell Technology, Astera Labs , and Club name Intel . Intel soared nearly 7% after its third-party chip manufacturing business landed its first named customer, cybersecurity provider Fortinet , under CEO Lip-Bu Tan. Encouraging as that is, Jim Cramer is just as pleased with the rallies in companies like 3M and General Motors following exceptional quarter reports. “We are seeing the kinds of moves that remind me that there are other opportunities besides tech to make money that are not connected to SK Hynix,” Jim said, referring to the South Korean memory-chip maker. 2. Salesforce was downgraded to a hold-equivalent rating from buy at Morgan Stanley, which also slashed its price target to $185 from $287. It comes less than two weeks after KeyBanc also downgraded Salesforce. While Morgan Stanley credited Salesforce for “actively disrupting itself” to position for the agentic AI era, analysts said Agentforce hasn’t ramped fast enough to drive an inflection in organic growth. Jim said he has “a sliver of hope that [Salesforce’s stock] actually will inflect or that it’s done going down.” On the other hand, Morgan Stanley is still bullish on our other enterprise software holding, Microsoft. While cutting their price target to $600 from $650, analysts kept a buy-equivalent rating. In justifying its optimism, Morgan Stanley cited expectations for Azure cloud growth to pickup, thanks to added compute capacity, and a belief that improved Copilot monetization is underway. For Jim, he said one of his biggest questions around Microsoft right now is its “contentious” relationship with longtime partner OpenAI as the ChatGPT creator plans for an initial public offering. He also noted that its struggling Xbox division is facing a variety of headwinds, including surging memory costs for gaming consoles. 3. Eli Lilly gained more than 1% despite news that it’s being sued by rival Novo Nordisk. Novo shares are lower on the day. The Danish competitor alleged that Lilly’s ad campaigns for its GLP-1 drugs are misleading consumers about superior efficacy in comparison to Novo’s Wegovy injectable. Novo said Lilly’s claims of superiority are “outdated” because they fail to reflect new evidence about a higher, more efficacious dose of Wegovy approved in March. Lilly’s ads are based on a head-to-head study comparing its Zepbound versus Wegovy that was published in the New England Journal of Medicine in May 2025 , before the higher dose of Wegovy was on the market. In a statement to our CNBC colleagues Tuesday, Lilly said it stands behind its advertising. “I kind of see this as a nothing burger,” said Jeff Marks, director of portfolio analysis for the Club. Jeff said the focus should remain on the strength of Lilly’s injectable GLP-1 business, particularly outside the U.S. , and whether obesity pill Foundayo can gain more traction to close the gap on Novo’s early lead in the oral market. “We’re sticking by Lilly,” added Jim. 4. Stocks covered in Tuesday’s rapid fire at the end of the video were: 3M , Danaher , General Motors , Haliburton , and D.R. Horton . (Jim Cramer’s Charitable Trust is long CRM, LLY, and MSFT. See here for a full list of the stocks.) As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust’s portfolio. If Jim has talked about a stock on CNBC TV, he waits 72 hours after issuing the trade alert before executing the trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB. NO SPECIFIC OUTCOME OR PROFIT IS GUARANTEED.Read More
About The Author
